| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021.
GATINEAU, Québec, Nov. 01, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company"), today announced a correction to its press release issued on October 31, 2022 announcing the Company's financial results for the fiscal year ended July 31, 2022.
In the table of financial results under the heading "Key Financial Results" in the press release, there was an error in the amounts disclosed for the "Total net loss and comprehensive loss" with respect to the three month periods ended April 30, 2022 and July 31, 2021 and for the year ended July 31, 2021. The balance of the information disclosed in the table was correct.
The revised table below is correct and reflects HEXO's recent income statement for the fourth quarter ("Q4'22") and fiscal year ended July 31, 2022 ("FY22"), as already disclosed properly in the Company's management's discussion and analysis ("MD&A") and consolidated financial statements (the "FS") and notes thereto as at and for the year ended July 31, 2022:
Key Financial Results
| For the three months ended |
For the years ended |
|||||||||||
| July 31, 2022 |
April 30, 2022 |
July 31, 2021 |
July 31, 2022 |
July 31, 2021 |
||||||||
| $ | $ | $ | $ | $ | ||||||||
| Revenue from sale of goods | 60,227 | 63,590 | 53,022 | 265,418 | 173,081 | |||||||
| Excise taxes | (17,910 | ) | (18,021 | ) | (14,365 | ) | (74,717 | ) | (49,583 | ) | ||
| Net revenue from sale of goods | 42,317 | 45,569 | 38,657 | 190,701 | 123,498 | |||||||
| Ancillary revenue | 177 | – | 103 | 402 | 271 | |||||||
| Net revenue | 42,494 | 45,569 | 38,760 | 191,103 | 123,769 | |||||||
| Cost of goods sold | (83,432 | ) | (55,179 | ) | (37,261 | ) | (282,985 | ) | (89,594 | ) | ||
| Gross loss before fair value adjustments | (40,938 | ) | (9,610 | ) | 1,499 | (91,882 | ) | 34,175 | ||||
| Fair value adjustments1 | 5,075 | 4,335 | 1,735 | 16,210 | 14,623 | |||||||
| Gross (loss)/profit | (35,863 | ) | (5,275 | ) | 3,234 | (75,672 | ) | 48,798 | ||||
| Operating expenses | (73,903 | ) | (127,704 | ) | (63,116 | ) | (992,053 | ) | (134,293 | ) | ||
| Loss from operations | (109,766 | ) | (132,979 | ) | (59,882 | ) | (1,067,725 | ) | (85,495 | ) | ||
| Other expenses and losses2 | 3,592 | (19,723 | ) | (9,630 | ) | (44,696 | ) | (29,664 | ) | |||
| Loss before tax | (106,174 | ) | (152,702 | ) | (69,512 | ) | (1,112,421 | ) | (115,159 | ) | ||
| Current and deferred tax recovery | 5,787 | 7,697 | 397 | 38,813 | 397 | |||||||
| Other comprehensive income | (1,980 | ) | (1,658 | ) | 1,156 | 17,323 | 1,152 | |||||
| Total net loss and comprehensive loss | (102,367 | ) | (146,663 | ) | (67,959 | ) | (1,056,285 | ) | (113,610 | ) | ||
| 1 Realized fair value amounts on inventory sold and unrealized gain on changes in fair value of biological assets. |
||||||||||||
| 2 Net interest expenses and non-operating income (expenses) | ||||||||||||
The original press release can be found here.
The following press release should be read in conjunction with the MD&A and FS. Additional information about HEXO is available on the Company's profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov, including the Company's Annual Information Form for the year ended July 31, 2022 dated October 31, 2022.
